Skip to main content

Table 2 Drug resistance patterns of Gram-negative bacterial isolates from urine samples of children at the FHCSH, Northwest, Ethiopia, February–April, 2019

From: Bacterial profile, antibiotic susceptibility pattern and associated risk factors of urinary tract infection among clinically suspected children attending at Felege-Hiwot comprehensive and specialized hospital, Northwest Ethiopia. A prospective study

Bacterial Iso.

Sen.

AMP

GEN

AMC

CTX

CTX

CIP

MER

COT

CAZ

CHL

TET

NIT

E. coli (n = 28)

S

–

13 (46.4)

5 (17.9)

24(85.7)

23(82.1)

21 (75)

27(96.4)

12(42.9)

21 (75)

23(82.1)

6 (21.4)

23(82.1)

I

–

7 (25)

7 (25)

1 (3.6)

1 (3.6)

1 (3.6)

–

4(14.2)

3 (10.7)

1 (3.6)

6 (21.4)

1(3.6)

R

28(100

8 (28.6)

16(57.1)

3 (10.7)

4 (14.3)

6 (21.4)

1 (3.6)

12(42.9

4 (14.3)

4(14.3)

16(57.2)

4(14.3)

K.pneumoniae (n = 5)

S

–

1 (20)

–

3 (60)

4 (70)

4 (70)

5 (100)

2 (40)

4 (80)

3 (60)

1 (20)

4 (80)

I

–

2 (40)

–

2 (40)

–

–

–

–

–

–

–

1 (20)

R

5 (100)

2 (40)

5 (100)

–

1 (20)

1 (20)

–

3 (60)

1 (20)

2 (40)

4 (80)

–

K.ozaniae (n = 1)

S

 

1 (100)

–

1 (100)

1 (100)

1 (100)

1 (100)

–

1 (100)

1 (100)

–

1 (100)

R

1 (100)

–

1 (100)

–

–

–

–

1 (100)

–

–

1 (100)

–

K.rhinoscleromatis (n = 1)

S

–

–

–

1 (100)

1 (100)

–

1 (100)

1 (100)

1 (100)

1 (100)

–

1 (100)

I

–

–

1 (100)

–

–

1 (100)

–

–

–

–

–

–

R

1 (100)

1 (100)

–

–

–

–

–

–

–

–

1 (100)

–

P.vulgaris (n = 1)

S

1 (100)

1 (100)

–

1 (100)

1 (100)

1 (100)

1 (100)

1 (100)

1 (100)

1 (100)

1 (100)

1 (100)

R

–

–

1 (100)

–

–

–

–

–

–

–

–

–

Citrobacter spps. (n = 6)

S

–

3 (50)

1 (16.7)

1 (16.7)

1 (16.7)

5 (83.3)

6 (100)

1 (16.7)

2 (33.33)

1(16.7)

–

3 (50)

I

–

2 (33.3)

–

–

–

1 (16.7)

–

–

2 (33.33)

1(16.7)

1 (16.7)

–

R

6 (100)

1 (16.7)

5 (83.3)

5 (83.3)

5 (83.3)

–

–

5 (83.3)

2 (33.33)

4(66.7)

5 (83.3)

3 (50)

Providencia spps. (n = 1)

S

–

1 (100)

–

1 (100)

1 (100)

1 (100)

1 (100)

–

1 (100)

1 (100)

–

1 (100)

I

–

–

1 (100)

–

–

–

–

–

–

–

–

–

R

1 (100)

–

–

–

–

–

–

1 (100)

–

–

1 (100)

–

Acinetobacter spps. n = 1

S

–

–

–

1 (100)

1 (100)

1 (100)

1 (100)

1 (100)

–

1 (100)

–

–

R

1 (100)

1 (100)

1 (100)

–

–

–

–

–

1 (100)

–

1(100)

–

Total n = 44

S

–

20(45.5)

5 (11.4)

33 (75)

33 (75)

34(77.3)

43(97.73)

18(40.9)

30(68.18)

33 (75)

8(18.18)

31(70.5)

I

–

11 (25)

9(20.46)

3 (6.8)

1 (2.3)

3 (6.8)

–

4 (9.1)

5 (11.37)

2 (4.5)

7 (15.9)

3 (6.8)

R

44(100)

13(29.6)

30(68.2)

8(18.2)

10(22.7)

7 (15.9)

1 (2.27)

22 (50)

9 (20.5)

9(20.5)

29(65.91)

10(22.5)

  1. Note: Sen. Sensitivity, AMP Ampicillin, GEN Gentamycin, AMC Augmentin, CXT Cefoxitin, CTX Cefotaxime, CIP Ciprofloxacin, MER Meropenem, COT Cotrimoxazole, CAZ Ceftazidime, CHL Chloramphenicol, TET Tetracycline, NIT Nitrofurantoin, S Sensitive, I Intermediate, R Resistant